This study aims to provide reasons for the poor sarcoma-related survival in patients with radiation-induced sarcoma (RIS). We performed a case-control study comparing sarcoma-related survival of 98 patients with RIS to that of 239 sporadic high-grade malignant sarcomas. The cumulative sarcoma-related 5-year survival was 32% (95% confidence interval (CI): 22-42) for patients with RISThe poor prognosis of RIS patients are not due to the previous radiotherapy